Medications
$340 million settlement proposed in EpiPen lawsuits
(HealthDay)—Pfizer Inc. has agreed to pay $345 million in a proposed settlement to resolve lawsuits over steep EpiPen price increases.
Jul 16, 2021
0
1
News tagged with mylan
Other
EU approves merger of Pfizer off-patent unit and Mylan
The European Commission on Wednesday authorised a merger of US drug giant Pfizer's off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.
Apr 22, 2020
0
4
Medications
Mylan in $30 mn US settlement over EpiPen probe disclosures
Mylan will pay $30 million to settle US charges it misled investors about probes of EpiPen payments under a federal health program, a US securities regulator announced Friday.
Sep 27, 2019
0
0
Medications
States seek to expand lawsuit against generic drugmakers
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.
Oct 31, 2017
1
0
Medications
EpiPen maker finalizes settlement for government overcharges
EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade—charges brought after rival Sanofi filed a whistleblower ...
Aug 17, 2017
0
0
Medications
Mylan, like other generic drugmakers, feels the pricing pain
Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory ...
Aug 9, 2017
0
0
Medications
Defect prompts Mylan to recall some Epipens
(HealthDay)—Mylan, the maker of the Epipen, says it is recalling "select lots" of the device used to treat dangerous allergic reactions due to a defect that might render it "difficult to activate in an emergency."
Apr 3, 2017
0
0
Medications
Mylan to pay $465 mn over EpiPen overcharges to Medicaid
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
0
5
Medications
Federal government: Mylan has been overcharging for EpiPens
Even the federal government is apparently paying too much for EpiPens, along with angry patients and insurers.
Oct 6, 2016
0
2
Medications
Mylan opens $27.14 billion hostile bid for Perrigo
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.
Sep 15, 2015
0
4
